News related to Rituxan (Rituximab) and/or conditions it is approved for
Low-Dose Rituxan OK for RA Retreatment
Source: MedPage Today Rheumatology [2014.07.08]
(MedPage Today) -- Halving the dose of rituximab when retreatment is needed may offer an effective long-term option for disease control in rheumatoid arthritis, a randomized trial suggested.
RheumShorts: Vasculitis, MRI, Anakinra for Knees (CME/CE)
Source: MedPage Today Radiology [2014.06.29]
(MedPage Today) -- The rheumatology literature this week explored whether or not patients with vasculitis treated with rituximab also need maintenance therapy, if MRI can predict later arthritis when disease is still subclinical, and how an interleukin (IL)-1 blocker could help in post-traumatic arthritis.
Source: MedicineNet Biological Therapy Specialty [2014.03.14]
Title: Non-Hodgkin's Lymphoma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/14/2014 12:00:00 AM